Seagen Inc SGT-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:20 AM CET
127.44quote price arrow down-1.72 (-1.33%)
52 week range
117.82 - 129.16
Loading...
  • Open127.44
  • Day High127.44
  • Day Low127.44
  • Prev Close127.20
  • 52 Week High129.16
  • 52 Week High Date01/27/23
  • 52 Week Low117.82
  • 52 Week Low Date01/10/23

Key Stats

  • Market Cap26,056.87M
  • Shares Out185.23M
  • 10 Day Average Volume90.18
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change8.18

KEY STATS

  • Open127.44
  • Day High127.44
  • Day Low127.44
  • Prev Close127.20
  • 52 Week High129.16
  • 52 Week High Date01/27/23
  • 52 Week Low117.82
  • 52 Week Low Date01/10/23
  • Market Cap26,056.87M
  • Shares Out185.23M
  • 10 Day Average Volume90.18
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change8.18

RATIOS/PROFITABILITY

  • EPS (TTM)-3.53
  • P/E (TTM)-36.10
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seagen Inc

 

Profile

MORE
Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in the development and sale of pharmaceutical products on its own, behalf or in collaboration with others. The Company is commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, and TUKYSA, or tucatinib...
Felix Baker Ph.D.
Independent Chairman of the Board
David Epstein
Chief Executive Officer, Director
Todd Simpson
Chief Financial Officer
Vaughn Himes Ph.D.
Chief Technical Officer
Chip Romp
Executive Vice President - Commercial U.S.
Address
21823 30Th Drive Se, Suite
Bothell, WA
98021
United States